Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety

Armin Barekatain; Mehdi Razavi

Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety

Tex Heart Inst J. 2012;39(4):532-4.

Authors

Armin Barekatain¹, Mehdi Razavi

Affiliation

¹ Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.

PMID: 22949771
PMCID: PMC3423266

No abstract available

Keywords: Anti-arrhythmia agents/classification/therapeutic use; adrenergic betaantagonists; atrial fibrillation/drug therapy; calcium channel blockers; heart rate/drug effects; potassium channel blockers; sodium channel blockers.

Publication types

Review

MeSH terms

Anti-Arrhythmia Agents / adverse effects
Anti-Arrhythmia Agents / classification
Anti-Arrhythmia Agents / therapeutic use*
Atrial Fibrillation / diagnosis
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / physiopathology
Heart Conduction System / drug effects*
Heart Conduction System / physiopathology
Humans
Patient Safety
Patient Selection
Practice Guidelines as Topic
Treatment Outcome

Substances

Anti-Arrhythmia Agents